Rationality of routine clinical use of olokizumab in COVID-19

Routine clinical use of olokizumab in COVID-19 is not recommended. The use of olokizumab is possible in clinical trials.

Bibliographic Details
Main Authors:	V. M. Tsvetov, A. V. Matveev, D. A. Sychev
Format:	Article
Language:	Russian
Published:	Izdatelstvo OKI 2020-10-01
Series:	Качественная клиническая практика
Subjects:	коронавирус олокизумаб covid-19
Online Access:	https://www.clinvest.ru/jour/article/view/530

Internet